Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to evaluate safety, tolerability, PK, PD, and immunogenicity of a single dose of GSK3862995B in healthy participants of Chinese, Japanese…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK3862995B

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: NOT_YET_RECRUITING